| Peer-Reviewed

Prevalence and Risk Factors Associated with Intestinal Parasitosis in HIV/AIDS Patients on HAART in the Ndop Health District, North West Region, Cameroon

Received: 20 May 2021     Accepted: 7 June 2021     Published: 25 January 2022
Views:       Downloads:
Abstract

Background: Intestinal parasites induce an immunological alteration that favors progression from HIV to AIDS. These enteric parasitic agents vary from patient to patient and from country to country depending on endemicity, seasonal variation of pathogens, and also the immune status of the patient. Therefore, studies are required to evaluate the spectrum of these parasites in specific locations to better plan their control. The purpose of this study was to determine the prevalence and risk factors associated with intestinal parasitosis in HIV/AIDS patients on Highly Active Antiretroviral Therapy (HAART). Methods: A cross sectional study was carried out from the month of March to July 2018 on HIV patients on HAART in the Ndop Health District, Cameroon. Three centers were selected for this study using a two-stage stratified sampling technique. Stool and blood were collected from 347 participants. Stool was examined for intestinal parasites using direct microscopy, fomol-ether concentration technique, and modified Ziehl-Neelsen staining technique. Blood collected was analyzed using a Pima Alere CD4+ T cell counter. A structured questionnaire was administered to collect socio-demographic and clinical data. Data were analyzed with SPSS version 20 and p value < 0.05 was considered statistically significant. Results: Three hundred and forty-seven (347) consented individuals were recruited into the study. The ages of study participants ranged between 22-78 years. The mean (±SD) age of the study participants was 42 (±10) years. Among the 347 participants, 67 (19.3% (CI = 15.3%-23.9%)) were infected with at least one intestinal parasite. Forty-two (12.1% (CI =8.9%-15.9%)) of study participants were infected with protozoan while 28 (8.1% (CI= 5.2%-11.0%)) were infected with helminths. Intestinal parasites identified included; Ascaris lumbricoides, Hookworm, Taenia spp, Schistosoma mansoni, Entamoeba histolytica/dispar, Cryptosproridum spp, Blastocystis hominis, Cyclospra spp, Isospora belli, Gardia intestinalis, and Entamoeba coli. Low CD4+ T lymphocyte cell counts were significantly associated (P< 0.01) with intestinal parasitic infection in HIV/AIDS patients on HAART. Conclusion: Intestinal parasites are a problem to HIV/AID patient on HAART. Screening for intestinal parasites in HIV/AIDS patients on HAART must be highlighted and awareness created among HIV/AIDS patients.

Published in Advances in Bioscience and Bioengineering (Volume 10, Issue 1)
DOI 10.11648/j.abb.20221001.11
Page(s) 1-10
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2022. Published by Science Publishing Group

Keywords

HIV/AIDS, Intestinal Parasites (IPs), Risk Factors, CD4+ T Lymphocyte Cell Count, Diarrhea, Highly Active Antiretroviral Therapy (HAART), Cameroon

References
[1] Jha AK, Uppal B, Chadha S, Bhalla P, Ghosh R, Aggarwal P, et al. Clinical and Microbiological Profile of HIV/AIDS Cases with Diarrhea in North India. J Pathog. 2012; 2012: 1–7.
[2] UNAIDS. Fact sheet - Latest global and regional statistics on the status of the AIDS epidemic. Unaids. 2017. pp. 8. Available from: http://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf. [Accessed March 20, 2018].
[3] Zida A, Sawadogo MP, Diallo I, Sangare I, Bamba S, Ouattara B, et al. Opportunistic and other intestinal parasites infections among HIV- positive patients in the era of combination antiretroviral therapy and preventive treatment in Ouagadougou, Burkina Faso. J HIV Clin Sci Res. 2017; 4 (2): 008-0014.
[4] Bissong M, Nguemain N, Ng’awono T, Kamga F. Burden of intestinal parasites amongst HIV/AIDS patients attending Bamenda Regional Hospital in Cameroon. African J Clin Exp Microbiol. 2015; 16 (3): 97.
[5] World Health Organization. Methodologies. Control and prevention of intestinal parasitic infections. WHO. 1987. p 49-65.pdf.
[6] Lawn SD, Butera ST. Contribution of Immune Activation to the Pathogenesis and Transmission of Human Immunodeficiency Virus Type 1 Infection. Clin Microbiol Rev. 2001; 14 (4): 753-77.
[7] Vouking MZ, Enoka P, Tamo CV, Tadenfok CN. Prevalence of intestinal parasites among HIV patients at the Yaoundé Central Hospital, Cameroon. Pan Afr Med J. 2014; 18: 136.
[8] Nsagha DS, Njunda AL, Assob NJC, Ayima CW, Tanue EA, kibu OD, et al. Intestinal parasitic infections in relation to CD4+ T cell counts and diarrhea in HIV/AIDS patients with or without antiretroviral therapy in Cameroon. BMC Infect Dis. 2015; 16 (1): 9.
[9] Chavan NS, Chavan SN. Intestinal parasitic infections in HIV infected patients. International J of Current Microbiology and Applied Sciences. 2014; 3 (2): 265–70.
[10] May MT, Ingle SM. Life expectancy of HIV-positive adults: a review. J Sex Health, 2011; 8 (4): 526–33.
[11] Brown M, Mawa PA, Kaleebu P, Elliott AM. Helminths and HIV infection: epidemiological observations on immunological hypotheses. Parasite. Par Immunol. 2006; 28 (11): 613–623.
[12] Borkow G, Bentwich Z. Chronic Immune Activation Associated with Chronic Helminthic and Human Immunodeficiency Virus Infections: Role of Hyporesponsiveness and Anergy. Clin Microbiol Rev. 2004; 17 (4): 1012–1030.
[13] Tom E. Medical Microbiology and Infection. John Wiley & Sons, 2012. p. 273.
[14] Subhash CP. Textbook of medical microbiology and immunology 2nd ed. Reed Elsevier India Private Limited, 2012.pdf.
[15] Tabue RN, Nem T, Atangana J, Bigoga JD, Patchoke S, Tchouine F. Anopheles ziemanni a locally important malaria vector in Ndop health district, north west region of Cameroon. J Par Vec. 2014, 7: 262.
[16] Ndop Council. Ndop Council development plan. National community development program (PNPD). 2012; p. 13-14.
[17] TP Bachur, JM Vale, IC Coêlho. Enteric parasitic infections in HIV/AIDS patients before and after the highly active antiretroviral therapy. Braz J Infect Dis. 2008; 12: 115-22.
[18] Djieyep A C., Djieyep, F D., Pokam B T., David D L., Kamga H L F. the Prevalence of Intestinal Coccidian Parasites Burden in HIV/AIDS Patients on Antiretroviral Therapy in HIV Centers in Mubi, Nigeria. African J Clin Exp Microbiol. 2014; 15 (3): 165–72.
[19] Yaykaran C, Tamoghna B. How to calculate sample size for different study designs in medical research. J Psychol Med. 2013; 35 (2): 121-126.
[20] Monica Cheesbrough. Laboratory practice in tropical countries part 1. 2nd ed. Cambridge university press. 2006. Chapter 5. Parasitological tests. p. 191-235.
[21] Akinbo FO, Okaka CE, Omoregie R. Prevalence of intestinal parasitic infections among HIV patients in Benin City, Nigeria. Libyan J Med. 2010; 5 (1): 0–6.
[22] Assefa S, Erko B, Medhin G, Assefa Z, Shimelis T. Intestinal parasitic infections in relation to HIV/AIDS status, diarrhea and CD4 T-cell count. BMC Infect Dis. 2009; 9: 1–6.
[23] Missaye A, Dagnew M, Alemu A, Alemu A. Prevalence of intestinal parasites and associated risk factors among HIV/AIDS patients with pre-ART and on-ART attending Dessie hospital ART clinic, Northeast Ethiopia. AIDS Res Ther. 2013; 10 (1): 1.
[24] Abdollahi A, Saffar H, Sheikhbahaei S, Rasoulinejad M. Is the evaluation of Entamoeba histolytica infection in HIV-positive patients of any clinical significance? Acta Med Iran. 2015; 53 (1): 46–50.
[25] Abaver DT, Nwobegahay JM, Goon DT, Iweriebor BC, Anye DN. Prevalence of intestinal parasitic infections among HIV/AIDS patients from two health institutions in Abuja, Nigeria. Afr Health Sci. 2011; 11 (1): 5–8.
[26] Udeh EO, Goselle ON, Popova D, Abelau M, Popov TV, Jean N DJ. The prevalence of intestinal protozoans in HIV/AIDS patients in Abuja, Nigeria. Sci World J. 2008; 3 (3): 1–4.
[27] Daryani A, Sharif M, Meigouni M, Mahmoudi FB, Rafiei A, Ghola- mi S, et al. Prevalence of intestinal parasites and profile of CD4+ counts in HIV+/AIDS people in north of Iran, 2007-2008. Pak J Biol Sci. 2009; 12 (18): 1277-81.
[28] Frederick O A, Richard O. Intestinal parasitic infections in human-immunodeficiency-virus-infected persons on highly active antiretroviral therapy in Benin City, Nigeria. GM BHS. 2012; (3): 119-122.
[29] Evering T, Weiss L. The immunology of parasite infections in immunocompromised hosts. Parasite Immunol. 2006; 28 (11): 549–65.
[30] Jayaram P. Paniker’s textbook of medical. 7 ed. Jaypee Brothers Medical Publishers (P) Ltd. 2013, p 110-188.
[31] Gedle D, Kumera G, Eshete T, Ketema K, Adugna H, Feyera F. Intestinal parasitic infections and its association with undernutrition and CD4 T cell levels among HIV/AIDS patients on HAART in Butajira, Ethiopia. J Health Popul Nutr. 2017; 36 (1): 15.
Cite This Article
  • APA Style

    Sangwe Bertrand Ngwa, Asongalem Emmanuel Acha, Ngwa Fabrice Ambe, Tanyi Pride Bobga, Jude Tsafack Zefack, et al. (2022). Prevalence and Risk Factors Associated with Intestinal Parasitosis in HIV/AIDS Patients on HAART in the Ndop Health District, North West Region, Cameroon. Advances in Bioscience and Bioengineering, 10(1), 1-10. https://doi.org/10.11648/j.abb.20221001.11

    Copy | Download

    ACS Style

    Sangwe Bertrand Ngwa; Asongalem Emmanuel Acha; Ngwa Fabrice Ambe; Tanyi Pride Bobga; Jude Tsafack Zefack, et al. Prevalence and Risk Factors Associated with Intestinal Parasitosis in HIV/AIDS Patients on HAART in the Ndop Health District, North West Region, Cameroon. Adv. BioSci. Bioeng. 2022, 10(1), 1-10. doi: 10.11648/j.abb.20221001.11

    Copy | Download

    AMA Style

    Sangwe Bertrand Ngwa, Asongalem Emmanuel Acha, Ngwa Fabrice Ambe, Tanyi Pride Bobga, Jude Tsafack Zefack, et al. Prevalence and Risk Factors Associated with Intestinal Parasitosis in HIV/AIDS Patients on HAART in the Ndop Health District, North West Region, Cameroon. Adv BioSci Bioeng. 2022;10(1):1-10. doi: 10.11648/j.abb.20221001.11

    Copy | Download

  • @article{10.11648/j.abb.20221001.11,
      author = {Sangwe Bertrand Ngwa and Asongalem Emmanuel Acha and Ngwa Fabrice Ambe and Tanyi Pride Bobga and Jude Tsafack Zefack and Neba Lawrence and Ngengang Venslas Mohmoh and Nsagha Dickson Shey},
      title = {Prevalence and Risk Factors Associated with Intestinal Parasitosis in HIV/AIDS Patients on HAART in the Ndop Health District, North West Region, Cameroon},
      journal = {Advances in Bioscience and Bioengineering},
      volume = {10},
      number = {1},
      pages = {1-10},
      doi = {10.11648/j.abb.20221001.11},
      url = {https://doi.org/10.11648/j.abb.20221001.11},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.abb.20221001.11},
      abstract = {Background: Intestinal parasites induce an immunological alteration that favors progression from HIV to AIDS. These enteric parasitic agents vary from patient to patient and from country to country depending on endemicity, seasonal variation of pathogens, and also the immune status of the patient. Therefore, studies are required to evaluate the spectrum of these parasites in specific locations to better plan their control. The purpose of this study was to determine the prevalence and risk factors associated with intestinal parasitosis in HIV/AIDS patients on Highly Active Antiretroviral Therapy (HAART). Methods: A cross sectional study was carried out from the month of March to July 2018 on HIV patients on HAART in the Ndop Health District, Cameroon. Three centers were selected for this study using a two-stage stratified sampling technique. Stool and blood were collected from 347 participants. Stool was examined for intestinal parasites using direct microscopy, fomol-ether concentration technique, and modified Ziehl-Neelsen staining technique. Blood collected was analyzed using a Pima Alere CD4+ T cell counter. A structured questionnaire was administered to collect socio-demographic and clinical data. Data were analyzed with SPSS version 20 and p value Results: Three hundred and forty-seven (347) consented individuals were recruited into the study. The ages of study participants ranged between 22-78 years. The mean (±SD) age of the study participants was 42 (±10) years. Among the 347 participants, 67 (19.3% (CI = 15.3%-23.9%)) were infected with at least one intestinal parasite. Forty-two (12.1% (CI =8.9%-15.9%)) of study participants were infected with protozoan while 28 (8.1% (CI= 5.2%-11.0%)) were infected with helminths. Intestinal parasites identified included; Ascaris lumbricoides, Hookworm, Taenia spp, Schistosoma mansoni, Entamoeba histolytica/dispar, Cryptosproridum spp, Blastocystis hominis, Cyclospra spp, Isospora belli, Gardia intestinalis, and Entamoeba coli. Low CD4+ T lymphocyte cell counts were significantly associated (PConclusion: Intestinal parasites are a problem to HIV/AID patient on HAART. Screening for intestinal parasites in HIV/AIDS patients on HAART must be highlighted and awareness created among HIV/AIDS patients.},
     year = {2022}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Prevalence and Risk Factors Associated with Intestinal Parasitosis in HIV/AIDS Patients on HAART in the Ndop Health District, North West Region, Cameroon
    AU  - Sangwe Bertrand Ngwa
    AU  - Asongalem Emmanuel Acha
    AU  - Ngwa Fabrice Ambe
    AU  - Tanyi Pride Bobga
    AU  - Jude Tsafack Zefack
    AU  - Neba Lawrence
    AU  - Ngengang Venslas Mohmoh
    AU  - Nsagha Dickson Shey
    Y1  - 2022/01/25
    PY  - 2022
    N1  - https://doi.org/10.11648/j.abb.20221001.11
    DO  - 10.11648/j.abb.20221001.11
    T2  - Advances in Bioscience and Bioengineering
    JF  - Advances in Bioscience and Bioengineering
    JO  - Advances in Bioscience and Bioengineering
    SP  - 1
    EP  - 10
    PB  - Science Publishing Group
    SN  - 2330-4162
    UR  - https://doi.org/10.11648/j.abb.20221001.11
    AB  - Background: Intestinal parasites induce an immunological alteration that favors progression from HIV to AIDS. These enteric parasitic agents vary from patient to patient and from country to country depending on endemicity, seasonal variation of pathogens, and also the immune status of the patient. Therefore, studies are required to evaluate the spectrum of these parasites in specific locations to better plan their control. The purpose of this study was to determine the prevalence and risk factors associated with intestinal parasitosis in HIV/AIDS patients on Highly Active Antiretroviral Therapy (HAART). Methods: A cross sectional study was carried out from the month of March to July 2018 on HIV patients on HAART in the Ndop Health District, Cameroon. Three centers were selected for this study using a two-stage stratified sampling technique. Stool and blood were collected from 347 participants. Stool was examined for intestinal parasites using direct microscopy, fomol-ether concentration technique, and modified Ziehl-Neelsen staining technique. Blood collected was analyzed using a Pima Alere CD4+ T cell counter. A structured questionnaire was administered to collect socio-demographic and clinical data. Data were analyzed with SPSS version 20 and p value Results: Three hundred and forty-seven (347) consented individuals were recruited into the study. The ages of study participants ranged between 22-78 years. The mean (±SD) age of the study participants was 42 (±10) years. Among the 347 participants, 67 (19.3% (CI = 15.3%-23.9%)) were infected with at least one intestinal parasite. Forty-two (12.1% (CI =8.9%-15.9%)) of study participants were infected with protozoan while 28 (8.1% (CI= 5.2%-11.0%)) were infected with helminths. Intestinal parasites identified included; Ascaris lumbricoides, Hookworm, Taenia spp, Schistosoma mansoni, Entamoeba histolytica/dispar, Cryptosproridum spp, Blastocystis hominis, Cyclospra spp, Isospora belli, Gardia intestinalis, and Entamoeba coli. Low CD4+ T lymphocyte cell counts were significantly associated (PConclusion: Intestinal parasites are a problem to HIV/AID patient on HAART. Screening for intestinal parasites in HIV/AIDS patients on HAART must be highlighted and awareness created among HIV/AIDS patients.
    VL  - 10
    IS  - 1
    ER  - 

    Copy | Download

Author Information
  • Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Buea, Buea, Cameroon

  • Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Buea, Buea, Cameroon

  • Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Buea, Buea, Cameroon

  • Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Buea, Buea, Cameroon

  • Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Buea, Buea, Cameroon

  • Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Buea, Buea, Cameroon

  • Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Buea, Buea, Cameroon

  • Department of Public Health and Hygiene, Faculty of Health Sciences, University of Buea, Buea, Cameroon

  • Sections